FDA
approval
· 2021-01-13
FDA Approved: ASHLYNA — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved a supplemental application for ASHLYNA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, manufactured by Glenmark…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ASHLYNA (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)